MedPath

Movano Health Provides Update on FDA Review of EvieMED Ring

• Movano Health is actively collaborating with the FDA to secure 510(k) clearance for its EvieMED Ring, a wearable medical device. • The FDA has recently requested additional clarifying information regarding the medical aspects of the EvieMED Ring, prompting further engagement from Movano. • Movano Health has resumed direct-to-consumer orders for the Evie Ring, featuring enhanced monitoring and personalized insights, since September 17, 2024.

Movano Health (Nasdaq: MOVE) has announced that it is actively addressing additional clarifying questions from the FDA regarding the medical aspects of its EvieMED Ring, as part of the final phase of the 510(k) application review process. The company had previously achieved a positive resolution after responding to initial FDA inquiries about the EvieMED's wellness features and metrics this summer.
John Mastrototaro, President and CEO of Movano Health, stated, "The FDA 510(k) clearance process is a rigorous one and we are pleased with the progress we continue to make. We are confident we can effectively address the follow up questions that the Agency has submitted, and we look forward to completing the final review of the EvieMED Ring."

EvieMED Ring Features

The EvieMED Ring is designed to provide medical device functionality through its pulse oximetry feature, as well as wellness metrics related to sleep, activity, and mood logging.

Direct-to-Consumer Sales

Separately, Movano Health announced the resumption of direct-to-consumer (D2C) orders for the Evie Ring on September 17, 2024. The company reports a positive initial response to product and operational improvements, including enhanced sleep, heart rate, and activity monitoring, expanded AI-generated personalized insights, and upgrades across manufacturing, logistics, and customer service, achieved through a fully organic marketing campaign.

About Movano Health

Movano Health, founded in 2018, is focused on developing healthcare solutions that bring medical-grade data to wearables. Their devices aim to capture a comprehensive picture of an individual's health data and translate it into personalized and intelligent insights.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

enVVeno Medical Seeks FDA Approval for VenoValve in Severe Deep Venous CVI

enVVeno Medical has submitted its Premarket Approval (PMA) application to the FDA for VenoValve, a device to treat severe deep venous Chronic Venous Insufficiency (CVI).
The VenoValve has breakthrough device designation, and four of five PMA modules are approved, with clinical data from the SAVVE trial under review.

enVVeno Medical Seeks FDA Approval for VenoValve and Completes enVVe Study

enVVeno Medical has submitted its PMA application to the FDA for VenoValve, a breakthrough device for severe deep venous Chronic Venous Insufficiency (CVI).
The FDA is expected to make a decision on VenoValve in the second half of 2025, potentially offering a new treatment for 2.5 million U.S. candidates.

enVVeno Medical Seeks FDA Approval for VenoValve in Severe Chronic Venous Insufficiency

enVVeno Medical has submitted its Premarket Approval (PMA) application to the FDA for VenoValve, a surgical replacement venous valve.
The VenoValve is intended for treating severe deep venous Chronic Venous Insufficiency (CVI), a condition affecting approximately 2.5 million people in the U.S. annually.

Movano Health's EvieMED Ring Receives FDA Clearance for Pulse Oximetry

Movano Health has secured FDA 510(k) clearance for the pulse oximeter in its EvieMED Ring, expanding its reach into healthcare B2B opportunities.
The EvieMED Ring combines medical-grade accuracy with the comfort of a wearable, potentially improving patient compliance in health monitoring.

Momentis Surgical Receives FDA Clearance for Second-Generation Anovo Robotic Surgery Platform

Momentis Surgical secured FDA 510(k) clearance for its second-generation Anovo robotic surgery platform, enhancing surgical capabilities through a single incision.
The upgraded Anovo system offers improved ergonomics, sensory feedback, and a video annotation layer to boost surgical team communication and learning.

iRhythm Receives FDA 510(k) Clearance for Zio AT Design Modifications

iRhythm Technologies received FDA 510(k) clearance for design modifications to its Zio AT cardiac monitoring system, addressing a prior warning letter.
The clearance involves updates to the device's design and labeling, marking progress in resolving issues identified at a manufacturing facility.

Envoy Medical's Acclaim Cochlear Implant Pivotal Study Receives FDA Approval

Envoy Medical received FDA approval for its IDE application to begin a pivotal study of the Acclaim® Fully Implanted Cochlear Implant, a novel hearing solution.
The Acclaim® device uses an implanted sensor to capture sound, leveraging the ear's natural anatomy, differentiating it from existing cochlear implants.

Envoy Medical's Acclaim Cochlear Implant Receives FDA Approval for Pivotal Clinical Study

Envoy Medical's Acclaim Cochlear Implant receives FDA approval for its Investigational Device Exemption (IDE) application, marking a significant step in its development.
The Acclaim device uses an implanted sensor to capture sound, differing from existing cochlear implants and potentially offering a more discrete option.

Movano Health Advances EvieMED Ring Toward FDA Clearance

Movano Health is set to respond to the FDA's clarifying questions for its EvieMED Ring, marking a crucial step in the 510(k) clearance process.
The EvieMED Ring integrates pulse oximetry with wellness metrics, such as sleep and activity tracking, to enhance clinical trials and patient monitoring.

iRhythm Technologies Receives FDA Clearance for Zio AT Design Updates, Stock Surges

iRhythm Technologies (IRTC) secured FDA 510(k) clearance for design updates to its Zio AT cardiac monitoring device, addressing prior regulatory concerns.
The approval marks a significant step in iRhythm's ongoing efforts to meet FDA compliance and enhance the quality and safety of its Zio AT system.

Reference News

[1]
Movano Health Provides Update on FDA Review of EvieMED Ring | MOVE Stock News
stocktitan.net · Oct 10, 2024

Movano Health received additional FDA questions about EvieMED Ring's medical aspects during 510(k) application review. T...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy